FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live STAR message board: Is STAR buy or sell? Should I buy STAR shares? Why are STAR shares falling? Should I invest in STAR stock?

forum

STAR Share Price Discussion

Strides Pharma Science Ltd.
NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Sector: Pharmaceuticals and health care

#STAR daily tf
Trading at critical support zone.
Breaking below this zone will result in fresh downside for the stock. Keep an eye on price action for breakdown or bear trap
STAR - chart - 281003
Like
Reply
Recent posts in STAR

Type
Buy
Instrument
STAR
Entry Price
₹411
Price@Trade
₹406.7
Target Price
₹414.1
Stop Price
₹407.9
Valid Till
Jul 1, 2020 3:20 AM
Margin
₹411,000 approx for 1000 Qty
Status
Exited before entry
Like
Reply (1)
T
Reputation: 12,578 • Jun 25 3:20 AM

Type
Buy
Instrument
STAR
Entry Price
₹434
Price@Trade
₹434.25
Target Price
₹460
Stop Price
₹419
Valid Till
Jul 24, 2020 3:20 AM
Margin
₹43,400 approx for 100 Qty
Status
Stoploss Hit
Exit Price
₹419
Net P&L
-₹1,500 (-3.46%)
Like
Reply (2)
N
Reputation: 3,957 • Jun 23 3:23 AM
Promoter Participaciones acquires 1.38% stake in Mahindra CIE, Lifecell offloads 1.07% in Strides Pharma
Beacon Trusteeship sold 5,57,271 shares (representing 0.69 percent of total paid up equity capital) in Tourism Finance Corporation at Rs 37.65 per share
Moneycontrol
Like
Reply

Type
Buy
Instrument
STAR
Entry Price
₹436
Price@Trade
₹444
Target Price
₹520
Stop Price
₹399
Valid Till
Jul 23, 2020 3:20 AM
Margin
₹21,800 approx for 50 Qty
Status
Active
Like
Reply (1)
N
Reputation: 3,957 • Jun 19 11:26 AM
China to revamp benchmark equity index, STAR as pursues growth
Red-chip stocks are those incorporated outside mainland China but listed on Chinese bourses.
The Economic Times
Like
Reply
N
Reputation: 3,957 • Jun 19 9:18 AM
COVID-19 treatment | Indian companies begin exports of Favipiravir, but wait for approval in India
Sources told Moneycontrol that Glenmark's Favipiravir is expected to get approval from drug regulator any moment, based on the intermediate data from the clinical trials given the urgency of the situation
Moneycontrol
Like
Reply